The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study
暂无分享,去创建一个
[1] A. Manni,et al. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar , 1991, Breast Cancer Research and Treatment.
[2] S. Romain,et al. Prognostic value of epidermal growth factor receptor in node-positive breast cancer , 1989, Breast Cancer Research and Treatment.
[3] J. Foekens,et al. Cell biological factors associated with the response of breast cancer to systemic treatment. , 1993, Cancer treatment reviews.
[4] J. Foekens,et al. The prognostic value of epidermal growth factor receptors determined both by immunohistochemistry and ligand binding assay, in primary epithelial ovarian cancer (OC) , 1993 .
[5] J. Foekens,et al. Prognostic factors and response to therapy in breast cancer. , 1993, Cancer surveys.
[6] J. Foekens,et al. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. , 1992, Cancer research.
[7] Y. Chiew,et al. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. , 1992, The Journal of biological chemistry.
[8] J. Foekens,et al. Clinical breast cancer, new developments in selection and endocrine treatment of patients , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[9] C. Osborne,et al. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. , 1992, Cancer research.
[10] M. Lynch,et al. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. , 1992, British Journal of Cancer.
[11] G. Scambia,et al. Significance of epidermal growth factor receptor in advanced ovarian cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] T. Benraad,et al. Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology. , 1992, European journal of cancer.
[13] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[14] J. Cairns,et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. , 1992, British Journal of Cancer.
[15] J. Mendelsohn. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. , 1992, Journal of the National Cancer Institute. Monographs.
[16] L. Skoog,et al. Heterogenous expression of the EGF-receptor in human breast carcinoma. , 1992, Anticancer research.
[17] J. Foekens,et al. Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. , 1991, Clinical chemistry.
[18] W. L. McGuire,et al. Breast cancer prognostic factors: evaluation guidelines. , 1991, Journal of the National Cancer Institute.
[19] J. Farndon,et al. Synthetic oligonucleotides as therapeutic agents. , 1991, British Journal of Cancer.
[20] A. Harris,et al. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[21] A. Harris. The epidermal growth factor receptor as a target for therapy. , 1990, Cancer cells.
[22] J. Foekens,et al. Hydroxyapatite Assay to Measure Epidermal Growth Factor Receptor in Human Primary Breast Tumours , 1990, Annals of clinical biochemistry.
[23] J. Foekens,et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.
[24] P. Hasleton,et al. Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. , 1989, British Journal of Cancer.
[25] E. Szabo,et al. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. , 1989, Cancer research.
[26] J. Farndon,et al. EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.
[27] J. Klijn,et al. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer , 1988, Cancer.
[28] Atsushi Ochiai,et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma , 1988, International journal of cancer.
[29] L. King,et al. Role of epidermal growth factor in carcinogenesis. , 1986, Cancer research.
[30] G. Sherbet,et al. EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.
[31] M. Bennett,et al. EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.
[32] G. Sherbet,et al. EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .
[33] J. Wittliff,et al. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.